Document ID: chunk:federal_register_of_legislation:F2020L01393:reg:9:p1
Version: federal_register_of_legislation:F2020L01393
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3448–6641

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, spinal adhesive arachnoiditis or death from spinal adhesive arachnoiditis is connected with the circumstances of a person's relevant service:
(1)          having severe spinal trauma involving the affected site within the ten years before the clinical onset of spinal adhesive arachnoiditis;
Note: severe spinal trauma is defined in the Schedule 1 - Dictionary.
(2)          undergoing spinal surgery involving the affected site within the ten years before the clinical onset of spinal adhesive arachnoiditis;
Note: Examples of spinal surgery include spinal fusion, laminectomy and discectomy.
(3)          having a lumboperitoneal shunt at the affected site at the time of the clinical onset of spinal adhesive arachnoiditis;
(4)          having a myelogram involving an injection of oil-soluble intrathecal radiological contrast agent before the clinical onset of spinal adhesive arachnoiditis;
(5)          having a myelogram involving an injection of water-soluble intrathecal radiological contrast agent from the specified list of radiological contrast agents within the ten years before the clinical onset of spinal adhesive arachnoiditis;
Note: specified list of radiological contrast agents is defined in the Schedule 1 - Dictionary.
(6)          having an injection of Thorotrast (thorium dioxide suspension) into the subarachnoid space before the clinical onset of spinal adhesive arachnoiditis;
(7)          having an in situ intrathecal drug delivery system at the affected site at the time of the clinical onset of spinal adhesive arachnoiditis;
(8)          having intrathecal injection of methotrexate or cytosine arabinoside within the one year before the clinical onset of spinal adhesive arachnoiditis;
(9)          having intrathecal injection of radioactive gold at the affected site before the clinical onset of spinal adhesive arachnoiditis;
(10)      having an infection from the specified list of infections before the clinical onset of spinal adhesive arachnoiditis;
Note: specified list of infections is defined in the Schedule 1 - Dictionary.
(11)      having a subarachnoid haemorrhage within the ten years before the clinical onset of spinal adhesive arachnoiditis;
(12)      having a spinal subdural haematoma at the affected site within the two years before the clinical onset of spinal adhesive arachnoiditis;
(13)      having severe spinal trauma involving the affected site within the ten years before the clinical worsening of spinal adhesive arachnoiditis;
Note: severe spinal trauma is defined in the Schedule 1 - Dictionary.
(14)      undergoing spinal surgery involving the affected site within the ten years before the clinical worsening of spinal adhesive arachnoiditis;
Note: Examples of spinal surgery include spinal fusion, laminectomy and discectomy.
(15)      having a lumboperitoneal shunt at the affected site at the time of the clinical worsening of spinal adhesive arachnoiditis;
(16)      having a myelogram involving an injection of oil-soluble intrathecal radiological contrast agent before